1 paper
Boris-Stephan Rauchmann, Jonathan Laib, Buse Ercik +2
Neurodegenerative diseases such as Alzheimer's disease (AD) require accurate and scalable tools for assessing disease severity, yet current clinical staging remains time-intensive…